Orchestra BioMed Holdings (OBIO) EPS (Weighted Average and Diluted) (2022 - 2025)
Historic EPS (Weighted Average and Diluted) for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to -$0.4.
- Orchestra BioMed Holdings' EPS (Weighted Average and Diluted) rose 243.9% to -$0.4 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.82, marking a year-over-year decrease of 1304.35%. This contributed to the annual value of -$1.66 for FY2024, which is 1183.57% down from last year.
- According to the latest figures from Q3 2025, Orchestra BioMed Holdings' EPS (Weighted Average and Diluted) is -$0.4, which was up 243.9% from -$0.5 recorded in Q2 2025.
- Orchestra BioMed Holdings' EPS (Weighted Average and Diluted)'s 5-year high stood at -$0.35 during Q2 2023, with a 5-year trough of -$0.77 in Q2 2022.
- Its 4-year average for EPS (Weighted Average and Diluted) is -$0.46, with a median of -$0.44 in 2024.
- In the last 5 years, Orchestra BioMed Holdings' EPS (Weighted Average and Diluted) surged by 5454.55% in 2023 and then tumbled by 2894.74% in 2025.
- Over the past 4 years, Orchestra BioMed Holdings' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.44 in 2022, then grew by 15.91% to -$0.37 in 2023, then dropped by 18.58% to -$0.44 in 2024, then increased by 8.83% to -$0.4 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.4 for Q3 2025, versus -$0.5 for Q2 2025 and -$0.49 for Q1 2025.